Sit Investment Associates Inc. lifted its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 7.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,724,706 shares of the company’s stock after buying an additional 125,599 shares during the period. Sit Investment Associates Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $24,836,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in BMEZ. Landscape Capital Management L.L.C. acquired a new stake in BlackRock Health Sciences Term Trust during the 4th quarter worth approximately $469,000. Virtu Financial LLC purchased a new stake in shares of BlackRock Health Sciences Term Trust during the fourth quarter worth approximately $206,000. Brooklyn FI LLC acquired a new stake in shares of BlackRock Health Sciences Term Trust during the fourth quarter worth $826,000. GWN Securities Inc. purchased a new position in BlackRock Health Sciences Term Trust in the 4th quarter valued at $404,000. Finally, Corient Private Wealth LLC increased its stake in BlackRock Health Sciences Term Trust by 24.9% in the 4th quarter. Corient Private Wealth LLC now owns 26,225 shares of the company’s stock valued at $378,000 after buying an additional 5,224 shares during the period.
BlackRock Health Sciences Term Trust Stock Performance
Shares of BlackRock Health Sciences Term Trust stock opened at $13.60 on Friday. BlackRock Health Sciences Term Trust has a one year low of $13.52 and a one year high of $16.75. The firm has a fifty day moving average of $15.59 and a two-hundred day moving average of $15.54.
BlackRock Health Sciences Term Trust Cuts Dividend
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Featured Articles
- Five stocks we like better than BlackRock Health Sciences Term Trust
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Stock Analyst Ratings and Canadian Analyst Ratings
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- How to Effectively Use the MarketBeat Ratings Screener
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.